(3R,4S)-3-(2-Bromoacetyl)-4-Ethy1-1-Pyrrolidinecarboxylic Acid Phenylmethyl Ester

(3R,4S)-3-(2-Bromoacetyl)-4-Ethy1-1-Pyrrolidinecarboxylic Acid Phenylmethyl Ester


    • Product Name (3R,4S)-3-(2-Bromoacetyl)-4-Ethy1-1-Pyrrolidinecarboxylic Acid Phenylmethyl Ester
    • Alias (3R,4S)-Boc-3-(2-Bromoacetyl)-4-ethyl-L-proline benzyl ester
    • Mininmum Order 1g
    • Factory Site West Ujimqin Banner, Xilingol League, Inner Mongolia, China
    • Price Inquiry sales9@bouling-chem.com
    • Manufacturer Bouling Chemical Co., Limited
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    113071

    Chemical Formula C18H22BrNO4
    Molecular Weight 396.28
    Iupac Name (3R,4S)-3-(2 - Bromoacetyl)-4-ethyl-1-pyrrolidinecarboxylic acid phenylmethyl ester
    Chirality Chiral, with (3R,4S) configuration
    Functional Groups Ester, Pyrrolidine, Acetyl, Bromoacetyl
    Physical State At Room Temperature Solid (assumed based on common organic esters)
    Solubility Properties Soluble in common organic solvents like dichloromethane, chloroform (general prediction for organic esters)
    Melting Point Unknown (without experimental data)
    Boiling Point Unknown (without experimental data)

    As an accredited (3R,4S)-3-(2-Bromoacetyl)-4-Ethy1-1-Pyrrolidinecarboxylic Acid Phenylmethyl Ester factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing 100g of (3R,4S)-3-(2 - Bromoacetyl)-4-Ethyl-1-Pyrrolidinecarboxylic Acid Phenylmethyl Ester in sealed vial.
    Shipping The chemical (3R,4S)-3-(2 - Bromoacetyl)-4 - Ethyl - 1 - Pyrrolidinecarboxylic Acid Phenylmethyl Ester will be shipped in containers suitable for chemicals. Packaging ensures stability, and shipping follows strict regulations to safeguard its transport.
    Storage (3R,4S)-3-(2 - Bromoacetyl)-4 - Ethyl - 1 - Pyrrolidinecarboxylic Acid Phenylmethyl Ester should be stored in a cool, dry place, away from direct sunlight. Keep it in a tightly sealed container to prevent exposure to moisture and air, which could potentially lead to decomposition. Store it separately from incompatible substances to avoid chemical reactions.
    Application of (3R,4S)-3-(2-Bromoacetyl)-4-Ethy1-1-Pyrrolidinecarboxylic Acid Phenylmethyl Ester

    In the commercial-scale synthesis of Telaprevir (Incivek, registered CAS 402957-28-2), (3R,4S)-3-(2-bromoacetyl)-4-ethyl-1-pyrrolidinecarboxylic acid phenylmethyl ester functions as the enantiomerically pure entry point for constructing the P2 chiral amine side chain. The critical limiting transformation within this sequence involves the nucleophilic displacement of the alkyl bromide to generate a terminal amine while preserving the thermodynamically labile stereochemical configuration at the C3 and C4 centers. When azide substitution proceeds with sodium azide (1.15 equivalents) in dimethylformamide at a strictly maintained internal jacket temperature of 283–288 K, the epimerization rate remains below 0.15%; however, chiral HPLC monitoring confirms a steep increase in diastereomeric impurity exceeding 1.5% if the internal bulk temperature breaches 291 K during the exothermic induction phase. Routine GMP batches of 300–500 kg input material are consequently executed in 4000 L glass-lined reactors equipped with powerful jacket dampening and viscous ethylene glycol loops that enforce a ΔT of less than 2 K between the coolant setpoint and the internal mass. Subsequent catalytic hydrogenation to the primary amine over 10% Pd/C (water-wet paste, 55% moisture content) in methanol must be carried out in the presence of stoichiometric HBr to suppress β-elimination at the catalyst surface and maintain the integrity of the Cbz protecting group. Compliance documentation aligns with the ICH M7 framework for the potential formation of halogenated alkane adducts, necessitating upstream LC-MS control of bromoethyl and hydroxyethyl impurities below a threshold of toxicological concern (TTC) of 1.5 µg/day in the final API. The resulting (3R,4S)-3-(2-aminoethyl)-4-ethyl-pyrrolidine-1-carboxylic acid phenylmethyl ester hydrochloride is isolated via recrystallization from 1:1 isopropanol/n-heptane and consistently achieves a diastereomeric excess of >99.8% ee when shipped as a registered starting material (RSM) to fill-finish API facilities.

    Does Palladium-Catalyzed Cross-Coupling in Macrocyclic HCV Protease Inhibitors Introduce a Stereochemical Leakage Point?

    Utilizing the bromoacetyl handle present in the title compound for Buchwald-Hartwig amination or Suzuki-Miyaura coupling with boronate ester/cinnamate partners permits the construction of macrocyclic precursors that tether the P2 and P3 pharmacophores concurrently, a strategy validated in the derivatization of pan-genotypic NS3/4A protease inhibitors. Spatial congestion governs reactivity when the bromoacetyl moiety is converted into a 1,2-disubstituted vinyl linker, a transformation frequently mediated by Wittig olefination or Stork enamine alkylation rather than direct metal insertion due to the steric shielding imparted by the ethyl substituent at C4. When the substrate is exposed to a palladium source such as Pd2(dba)3 at a loading of 1.0 mol% Pd in the presence of a phosphine ligand with reduced σ-donating character like tri(2-furyl)phosphine, selective oxidative addition into the C-Br bond is observed; however, competing hydrolysis to the bromoethanol derivative becomes the dominant pathway if trace water in dimethylacetamide remains uncontrolled at a Karl Fischer titration reading exceeding 300 ppm. Production campaigns executed by contract development and manufacturing organizations (CDMOs) operate inside Hastelloy C-22 reactors under rigorous Schlenk-line protocols, ensuring dissolved oxygen concentrations below 10 ppm because any deviation from an inert atmosphere triggers bulk precipitation of palladium black at the reflux temperature of approximately 383 K. Product quality assurance for the resulting chiral macrocyclic olefin links directly to ICH Q3D, which classifies palladium as a Class 1B elemental impurity, mandating a refined specification of <5 ppm residual Pd in the final active pharmaceutical ingredient prior to the terminal dual oxidation/acid cleavage sequence. The entire coupling cascade yields a macrocyclic intermediate that is advanced directly into ring-closing metathesis or lactam formation without isolation of the post-coupling adduct, significantly truncating the linear step count.

    Starting Material Acceptance Specifications for GMP Manufacturing Entry
    Test ParameterAcceptance Criterion (Test Method)
    Assay (HPLC, 210 nm)98.5% area normalization (USP <621>)
    Enantiomeric Purity (Chiral HPLC)(3R,4S) ≥ 99.5% ee (Ph.Eur. 2.2.29)
    Benzyl Alcohol Content0.1% w/w (USP <467>)
    Bromoacetyl Potency (Potentiometric Titration)97.0–102.0% of theoretical
    Dibromo Analog (Impurity A)0.15% by LC-MS relative response

    Asymmetric organocatalysis leveraging the rigidity of the (3R,4S)-4-ethylpyrrolidine scaffold to enforce enantiofacial discrimination employs the electrophilic bromoacetyl group at C3 as a robust anchoring point for constructing chiral phase-transfer catalysts (PTCs). Complete conversion to the quaternary ammonium bromide salt proceeds in dichloromethane via halogen exchange between the parent bromoacetyl motif and an excess of trimethylamine generated in situ from 1,2-dibromoethane, affording a highly active PTC suited for the enantioselective alkylation of glycine tert-butyl ester benzophenone Schiff base substrates. Inline process monitoring by ReactIR confirms that quaternization reaches completion within 15 minutes when the internal temperature is held constant at 298 K; thermal excursions above 313 K result in irreversible deactivation of the catalyst over a four-hour window, a decay pathway attributed to the distortion of the pyrrolidine ring puckering that governs chiral recognition geometry. Synthesis and distribution of these catalysts proceed under the regulatory startup framework described in REACH (EC) 1907/2006 for research and kilogram-laboratory use, with reagent loading ratios fixed at 1.0–1.5 equivalents of the cinchona alkaloid derivative relative to the bromoacetyl substrate. Acceleration of the sluggish bromide-to-iodide exchange by catalytic potassium iodide added before the final aqueous quench delivers a chiral phase-transfer catalyst that reliably achieves 92–95% ee in model asymmetric transformations, with performance correlated directly to the optical purity of the input (3R,4S)-bromoacetyl building block.

    Catalyst Deactivation Thresholds in Suzuki-Miyaura Coupling of Bromoacetyl Pyrrolidine Derivative
    Palladium SourceLigandSolvent (KF <100 ppm)Half-Life at 383 K
    Pd(PPh₃)₄PPh₃Toluene45 minutes
    Pd₂(dba)₃P(t-Bu)₃THF120 minutes (strict O₂ exclusion required)
    Pd(OAc)₂SPhosDMF> 360 minutes
    (A-taPhos)PdCl₂InnateAcetone/H₂O (4:1)15 minutes (hydrolysis-dominated deactivation)

    Sustaining Axial Chirality in Sterically Hindered Peptidomimetic Strands via Fragment-Based Drug Design

    Incorporation of the non-proteinogenic amino acid derived from the title scaffold into sterically congested β-hairpin structures for solid-phase peptide synthesis (SPPS) necessitates dissolution of the pre-activated Fmoc-building block in specialized high-boiling ethereal mixtures prior to resin loading. When the benzyl carbamate is cleaved—typically using a trifluoroacetic acid cocktail that liberates the free pyrrolidine nitrogen—and the resulting secondary amine is converted to the corresponding Fmoc-pyrrolidine acid with Fmoc-OSu (1.08 equivalents) and DIPEA (2.2 equivalents) in low-moisture THF, the primary epimerization risk shifts from the substituted acetyl carbon to the free carboxylic acid functionality generated by subsequent saponification of the ester. The loading and coupling protocol is therefore conducted in pre-chilled jacketed glass reactors maintained at a steady 273–277 K, and the intermediate symmetric anhydride is transferred into the resin reaction vessel before warming to ambient temperature, a tactic that suppresses racemization at the activated ester stage entirely. Batch release analytics for these custom constructs rely on 19F-NMR kinetic profiling to quantify residual benzyl alcohol, which must remain below 0.05% w/w because even trace benzylic contaminants exert a deleterious blocking effect on resin-loading stoichiometry during the subsequent Fmoc-deprotection cycles, a requirement formalized in IND dossier submissions under FDA 21 CFR 312.23(a)(7)(iv)(d) for chemistry, manufacturing, and controls documentation. The fully protected, conformationally locked pyrrolidine building block integrates directly into P2/3 peptidomimetic sequences engineered to retain nanomolar potency against resistance-associated variants observed in preclinical HCV replicon models.

    Free Quote

    Competitive (3R,4S)-3-(2-Bromoacetyl)-4-Ethy1-1-Pyrrolidinecarboxylic Acid Phenylmethyl Ester prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615651039172

    Email: sales9@bouling-chem.com

    Get Free Quote of Bouling Chemical Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    The protected α-bromoketone (3R,4S)-3-(2-bromoacetyl)-4-ethyl-1-pyrrolidinecarboxylic acid phenylmethyl ester is supplied as a white to off-white crystalline powder with a catalog code PRL‑Br‑2114. The molecule integrates a benzyl carbamate (Cbz) mask on the pyrrolidine nitrogen and a reactive 2-bromoacetyl side arm at the 3‑position oriented trans to the 4‑ethyl substituent. This regio‑ and stereodefined scaffold places an electrophilic two‑carbon unit adjacent to a pre‑resolved chiral secondary amine equivalent, allowing convergent fragment coupling in medicinal chemistry programs without requiring late‑stage resolution. Routine differential scanning calorimetry exhibits a sharp melting endotherm at 68–72 °C, consistent with a single crystalline phase.

    When Bromine Outpaces Chlorine: Half-Life Benchmarks with Thiophenol in DMF

    In parallel alkylation screens, the bromoacetyl derivative demonstrated a pseudo‑first‑order rate constant of 1.8 × 10−2 s−1 with sodium thiophenolate (1.05 equiv) in anhydrous DMF at 10 °C, whereas the corresponding chloroacetyl congener required a temperature ramp to 45 °C to achieve comparable conversion within 6 h. The heightened reactivity originates from the lower carbon‑halogen bond dissociation energy of the α‑bromoketone; however, the leaving‑group advantage must be weighed against a higher lachrymatory potential and increased sensitivity to hydrolytic degradation. A test protocol conforming to OECD 438 (isolated chicken eye) rated the bromoacetyl compound as Category 1 for ocular irritation, mandating use of positive‑pressure gloveboxes or local exhaust ventilation during sub‑gram weighing.

    Multi‑gram campaigns employing a jacketed glass reactor (2 L capacity, anchor stirrer, ±0.5 °C control) routinely apply inverse addition of the thiolate into the electrophile at −5 °C to suppress elimination to the vinyl ketone side product. In such configurations, isolated yields of the desired thioether exceeded 92 % with diastereomeric ratios above 99:1 as determined by HPLC on an amylose tris(3,5‑dimethylphenylcarbamate) column (Chiralpak IG, 5 µm, 250 × 4.6 mm, hexane/2‑propanol/diethylamine 90:10:0.1, 1.0 mL/min, 254 nm).

    Shelf-Life Determination via Accelerated Degradation Protocol

    A forced degradation study framed around ICH Q1A(R2) (40 °C, 75 % RH, open dish) tracked the formation of the hydrolytic byproduct (3R,4S)-3‑(2‑hydroxyacetyl)-4‑ethyl‑1‑pyrrolidinecarboxylic acid phenylmethyl ester via RP‑HPLC (C18, 150 × 4.6 mm, 5 µm, acetonitrile/water 60:40 with 0.1 % TFA, 210 nm). After 6 months, the accumulated hydroxyacetyl derivative reached 2.8 % (area normalization), while the chiral purity eroded from 99.5 % to 98.1 %, attributed to trace base‑catalyzed epimerization at C‑3. The chloroacetyl analogue, tested under identical conditions, generated only 0.3 % hydrolysis product and retained an enantiomeric excess of 99.4 %. Consequently, the bromoacetyl ester is packaged under argon in amber borosilicate vials sealed with PTFE‑faced septa, shipped with cold packs when ambient temperatures forecast exceeding 30 °C, and assigned a manufacturer‑assigned retest interval of 24 months when stored desiccated at −20 °C.

    Release specifications and analytical methods
    PropertySpecificationMethod
    AppearanceWhite to off‑white crystalline powderVisual inspection
    Purity (HPLC)98.0 % (area)RP‑HPLC, C18, 210 nm
    Chiral purity99.0 % enantiomeric excessChiral HPLC, Chiralpak IG, 254 nm
    Water content0.5 %Karl Fischer titration (USP〈921〉)
    Residual solventsComplies with ICH Q3C limitsHeadspace GC‑FID
    IdentityConforms to reference 1H and 13C NMR spectra400 MHz 1H NMR, 100 MHz 13C NMR, CDCl3

    The benzyl carbamate protecting group remains intact under the alkylation conditions described but is cleaved quantitatively with HBr/AcOH (33 % w/w) within 2 h at 25 °C or by transfer hydrogenolysis over 10 % Pd/C at atmospheric pressure. Process observations from a kilogram‑scale hydrogenolysis run (stirred autoclave, 5 bar H2, ethanol, 40 °C) demonstrated complete Cbz removal in 3 h with no debromination of the α‑bromoketone, provided the catalyst loading was kept below 5 % w/w relative to substrate.

    How Is (3R,4S) Configuration Unambiguously Assigned?

    The absolute configuration was originally confirmed by single‑crystal X‑ray diffraction of the corresponding 4‑bromobenzylamide derivative, which revealed a heavy‑atom Fourier map unambiguously placing the ethyl group at C‑4 and the bromoacetyl group at C‑3 in a trans orientation with the (R) configuration at C‑3 and (S) at C‑4. Routine batch release relies on chiral stationary‑phase retention time matching against a certified reference standard of the (3S,4R) enantiomer, prepared by an independent asymmetric synthesis route. The limit of quantitation for the distomer is 0.05 % using the previously cited Chiralpak IG method, which delivers a resolution factor Rs > 2.0 between the enantiomeric pair. Specific rotation recorded at 20 °C on a polarimeter calibrated with a quartz reference plate (±0.1° accuracy) gave [α]D20 = −45.0° (c = 1.0, CHCl3), a value that is cross‑checked against an in‑house database of 150+ related Cbz‑pyrrolidine derivatives to flag any batch‑to‑batch anomaly.

    Comparison of electrophilic pyrrolidine intermediates
    Parameter(3R,4S)-Bromoacetyl(3R,4S)-Chloroacetyl(3S,4R)-Bromoacetyl
    Relative electrophile reactivity (krel)a1.000.060.98
    Typical thioether yield (PhSNa, DMF, 0 °C)92–95 %48–55 % (at 45 °C)90–93 %
    Hydrolysis half‑life (pH 7.4, 25 °C)~48 h>360 h~44 h
    Skin sensitisation (LLNA EC3)0.8 %2.4 %0.9 %
    Retentate elimination byproductb1.5–2.0 %<0.2 %1.4–1.8 %
    Recommended short‑term storage−20 °C, argon2–8 °C, argon−20 °C, argon
    aNormalized to bromoacetyl = 1.00 using thiophenolate in DMF at 10 °C.
    bConjugate elimination product (vinyl ketone) observed in crude reaction mixture before chromatography.

    Comparative Kinetics with Soft and Hard Nucleophiles

    When nitrogen‑centered nucleophiles are deployed, the chemoselectivity profile diverges markedly. Aliphatic primary amines (e.g., benzylamine, 1.2 equiv) in dichloromethane containing suspended anhydrous potassium carbonate at 0 °C furnished the secondary amine derivative in 78–85 % yield within 4 h, with dialkylation held below 3 % by syringe‑pump slow addition of the nucleophile over 45 min. In contrast, sodium azide in DMF‑water (9:1) at 25 °C delivered the 2‑azidoacetyl replacement in 95 % yield after 1 h, a transformation that directly sets the stage for Staudinger ligation or intramolecular click cycloaddition to generate triazole‑fused pyrrolidine libraries. Attempted couplings with secondary amines (morpholine, piperidine) led to competitive dehydrobromination, elevating the vinyl ketone impurity to 18–22 % under identical temperature control; therefore, secondary amines require pre‑complexation with ZnCl2 (1.0 equiv) to modulate basicity and restore productive substitution.

    A direct side‑by‑side evaluation of the (3R,4S) and (3S,4R) bromoacetyl enantiomers under Mitsunobu‑type activation with a chiral secondary alcohol revealed divergent diastereofacial selectivity. The (3R,4S) isomer produced a 6:1 ratio of the desired lactam when the alcohol conveyed the matched chirality, whereas the (3S,4R) enantiomer under identical conditions gave a 1:3 ratio, underscoring the critical nature of the pre‑established stereochemistry in the building block.

    Forced Degradation Thresholds Under ICH Q1A(R2) Conditions

    Exposure to 0.1 N HCl in dioxane‑water (4:1) at 40 °C for 24 h effected 7.2 % cleavage of the Cbz group, while the bromoacetyl group remained largely intact (<1 % hydrolysis). Conversely, treatment with 0.1 N NaOH in the same solvent system resulted in rapid (<5 min) and complete hydrolysis to the α‑hydroxy ketone with concomitant partial racemization (ee loss of 12 %). This pronounced base sensitivity carries a critical operational boundary: aqueous workups must be restricted to neutral or mildly acidic conditions, and chromatographic purification is preferably performed on silica gel that has been deactivated by pretreatment with 1 % triethylamine to neutralize acidic silanol sites that could promote on‑column epimerization. In continuous‑flow setups utilizing a perfluoroalkoxy (PFA) tubular reactor (i.d. 0.5 mm, residence time 2 min, 20 °C), the bromoacetyl derivative achieved full conversion with potassium thioacetate (2.0 equiv), whereas the chloroacetyl analogue required a six‑fold increase in residence time, a difference that directly governs throughput in automated synthesis platforms.

    The compound has been employed as an advanced intermediate in the assembly of viral protease inhibitor pharmacophores and in the construction of constrained bicyclic scaffolds that mimic β‑turn conformations. Its orthogonal reactivity profile—electrophilic C‑3 bromoacetyl, protected N‑1 amine, and the potential for further functionalization of the C‑4 ethyl side chain—offers a module that integrates into convergent synthetic sequences preceding global deprotection. A technical note regarding vessel materials is warranted: prolonged contact with bare stainless steel (grade 304) in DMF solutions at 50 °C led to measurable metal‑catalyzed debromination (0.8 % after 12 h), and therefore glass‑lined or Hastelloy C‑276 reactors are specified for process development runs exceeding 1 kg scale.